Rebecca Christofferson

Associate Professor Louisiana State University

  • Baton Rouge LA

Dr. Christofferson is an international expert on emerging zoonotic and mosquito-borne viruses.

Contact

Louisiana State University

View more experts managed by Louisiana State University

Areas of Expertise

Neglected Tropical Diseases
Viruses
Epidemiology
Infectious Disases
Biosecurity
Diagnostics

Biography

Rebecca Christofferson is a PhD-trained virologist and infectious disease epidemiology experienced in translating complex data into actionable insights. Her work spans laboratory and field-based research on vector-borne viruses, outbreak modeling and response, and translational outreach grounded in public health impact and global biosecurity.

Research Focus

Arbovirus Ecology & Epidemiology

Dr. Christofferson’s research focuses on arbovirus ecology and epidemiology, examining how environmental conditions and mosquito biology drive transmission of Zika, dengue, chikungunya, and West Nile viruses. She blends vector-competence experiments, field mosquito surveillance, and climate-based modeling to predict outbreak risk and guide Gulf Coast public-health and control strategies.

Answers

What can you do to prevent rabies exposure?
Rebecca Christofferson

Never handle wildlife if you don't have to, particularly bats. Also, don't approach random animals whose vaccination status you don't know. Also get your pets vaccinated and encourage pet vaccination in your network.

Can you explain what prophylaxis is? Can people get vaccinated against rabies?
Rebecca Christofferson

Prophylaxis in treatment given before the disease presents. So someone who was at risk for having had a rabies exposure will often receive treatment - the vaccine and immunoglobulin shots - "just in case." This is because once someone starts to show signs of disease, rabies is almost always fatal. There is a vaccine against rabies for people, and anyone can get it. However, it is strongly recommended for animal workers like animal control, veterinary professionals and paraprofessionals, etc. people traveling to areas where rabies is endemic are often recommended to get the vaccines; as well as people who like to explore caves or other places with lots of bats. It is a three shot course and not cheap. But you need all three shots for it to be fully effective.

Who is at high risk for rabies?
Rebecca Christofferson

People who work with or near animals - pets or wildlife - are at risk. People who have had contact with a wild animal - in particular bats or raccoons - are also at risk. Anyone who has a broken skin contact with an animal with unknown vaccination status should seek immediate medical attention.

Show More +

Education

Louisiana State University

Ph.D.

2011

Louisiana State University

MApSt

2005

Louisiana State University

B.S.

2002

Accomplishments

Pereboom Alumni Association Professor of Excellence Ogden Honors College

2022-2025

2021 Worley Professor of Excellence

2021

Professorship awarded to one faculty annually at LSU for excellence in innovation and scholarship

Zoetis Research Award

2018

Excellent in research award for School of Veterinary Medicine

Media Appearances

America’s first severe case of bird flu confirmed in Louisiana

CNN  

2024-12-18

“The cases across the US are a constellation of spillovers,” said Dr. Rebecca Christofferson, a virologist at Louisiana State University’s School of Veterinary Medicine. Experts still don’t understand exactly how these spillovers are happening and the specific factors that increase a person’s risk.

View More

LSU Vet Professor weighs in on potential poultry vaccine for bird flu

KPLC  tv

2025-02-24

Rebecca Christofferson is an associate professor at the LSU School of Veterinary Medicine who specializes in infectious disease transmission.

“In 2023, France actually rolled out a bird flu vaccine for their duck industry and saw great success there,” Christofferson said.

View More

One bird flu case found in Louisiana out of 60 in the country this year

WBRZ-ABC  tv

2024-12-17

BATON ROUGE — The Louisiana Department of Health announced its first confirmed human case of bird flu. The person, who is from southwestern Louisiana and is currently in the hospital, is one of 60 cases from around the country as of December 2024.

Of the 60 confirmed virus cases in humans, none of them have involved human-to-human transmission.

"There are spillover risks, and that is what we are seeing right now, which is when a virus comes from an animal population into the human population," said Dr. Rebecca Christofferson from LSU's Veterinarian School.

View More

Show All +

Articles

Exploring the transmission modalities of Bunyamwera virus

Experimental Biology and Medicine

2024

Bunyamwera virus (BUNV) (Bunyamwera orthobunyavirus) has been found in Sub-Saharan Africa and demonstrated recently as cocirculating with Rift Valley Fever Virus (RVFV). Little is known regarding the breadth of transmission modalities of Bunyamwera. Given its co-occurence with RVFV, we hypothesized the transmission system of BUNV shared similarities to the RVFV system including transmission by Ae. aegypti mosquitoes and environmentally mediated transmission through fomites and environmental contamination.

View more

Investigating the Effects of Microclimate on Arboviral Kinetics in Aedes aegypti

Pathogens

2024

Aedes aegypti are indoor-dwelling vectors of many arboviruses, including Zika (ZIKV) and chikungunya (CHIKV). The dynamics of these viruses within the mosquito are known to be temperature-dependent, and models that address risk and predictions of the transmission efficiency and patterns typically use meteorological temperature data. These data do not differentiate the temperatures experienced by mosquitoes in different microclimates, such as indoor vs. outdoor.

View more

Predicting severe COVID-19 using readily available admission indicators: SpO2/FiO2 ratio, comorbidity index, and gender

Experimental Biology and Medicine

2024

The focus of this study was to identify risk factors for severe and critical COVID-19, evaluate local respiratory immune responses to SARS-CoV-2 infection, and develop a prognostic tool for COVID-19 severity using accessible early indicators.

View more

Show All +